Vireo Growth Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Vireo Growth hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

-0.9%

Rückkaufsrendite

Gesamte Aktionärsrendite	-0.9%
Zukünftige Dividendenrendite	n/a
Wachstum der Dividende	n/a
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Ausschüttungsquote	n/a

Jüngste Updates zu Dividenden und Rückkäufen

Keine Aktualisierungen

Recent updates

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 12

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Aug 10

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Jun 01

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Apr 06

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Feb 01

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Jan 25

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von VREO in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von VREO gestiegen sind.

Dividendenrendite im Vergleich zum Markt

Vireo Growth Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von VREO im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (VREO)	n/a
Untere 25 % des Marktes (CA)	1.8%
Markt Top 25 % (CA)	6.2%
Branchendurchschnitt (Pharmaceuticals)	2.4%
Analystenprognose (VREO) (bis zu 3 Jahre)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von VREO im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von VREO im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von VREO, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da VREO keine Ausschüttungen gemeldet hat.

Vireo Growth Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Third quarter 2024 earnings released: US$0.024 loss per share (vs US$0.037 loss in 3Q 2023)

Vireo Growth Inc. announced that it expects to receive $10 million in funding

Vireo Growth Inc. to Report Q3, 2024 Results on Nov 13, 2024

New minor risk - Market cap size

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Vireo Growth Inc. Announces CFO Changes

Vireo Growth Inc. Announces Resignation of Josh Rosen as Director

Insufficient new directors

New major risk - Shareholder dilution

Vireo Growth Inc. announced that it has received $5.3875 million in funding

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Second quarter 2024 earnings released: US$0.005 loss per share (vs US$0.057 loss in 2Q 2023)

Vireo Growth Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Goodness Growth Holdings, Inc. announced that it expects to receive $0.7 million in funding

First quarter 2024 earnings released: US$0.047 loss per share (vs US$0.066 loss in 1Q 2023)

Goodness Growth Holdings, Inc. Appoints Josh Rosen as Chief Executive Officer

Goodness Growth Holdings, Inc. to Report Q1, 2024 Results on May 07, 2024

Goodness Growth Holdings, Inc., Annual General Meeting, Jun 21, 2024

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Goodness Growth Holdings, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings released: US$0.19 loss per share (vs US$0.33 loss in FY 2022)

Goodness Growth Holdings, Inc. to Report Q4, 2023 Results on Mar 28, 2024

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Goodness Growth Holdings, Inc. Announces Departure of Michael Schroeder as General Counsel & Chief Compliance Officer Effective December 15, 2023

Third quarter 2023 earnings released: US$0.037 loss per share (vs US$0.066 loss in 3Q 2022)

Goodness Growth Holdings, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Goodness Growth Holdings, Inc. Announces CFO Changes

New major risk - Financial position

Second quarter 2023 earnings released: US$0.084 loss per share (vs US$0.048 loss in 2Q 2022)

Goodness Growth Holdings, Inc. to Report Q2, 2023 Results on Aug 14, 2023

New minor risk - Shareholder dilution

First quarter 2023 earnings released: US$0.066 loss per share (vs US$0.11 loss in 1Q 2022)

Goodness Growth Holdings, Inc. to Report Q1, 2023 Results on May 15, 2023

Goodness Growth Holdings, Inc. Announces Management Changes

Price target decreased to CA$0.85

Goodness Growth Holdings, Inc. Announces Departure of Christian Gonzalez-Ocasio as Chief Operating Officer

Goodness Growth Holdings, Inc Appoints Josh Rosen to the Role of Interim President

Goodness Growth Holdings, Inc. to Report Q3, 2022 Results on Nov 14, 2022

Goodness Growth Holdings, Inc., Annual General Meeting, Nov 18, 2022

Goodness Growth Holdings, Inc. Announces Launch of Boundary Waters Pre-Rolls in Minnesota

Second quarter 2022 earnings released: US$0.048 loss per share (vs US$0.044 loss in 2Q 2021)

Goodness Growth Holdings, Inc. Announces Unaudited and Condensed Impairment Results for the Quarter Ended June 30, 2022

Goodness Growth Holdings, Inc. Launches Cannabis-Infused Gummies in Minnesota

Goodness Growth Holdings Launches Hicolor™ Cannabis Chews in New York

First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.059 loss in 1Q 2021)

Goodness Growth Holdings, Inc. Reports Consolidated Impairment of Long-Lived Assets for the Three Months Ended March 31, 2022

Price target increased to CA$4.00

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Price target increased to CA$4.00

Verano Holdings Corp. (CNSX:VRNO) entered into a definitive arrangement to acquire Goodness Growth Holdings, Inc. (CNSX:GDNS) for approximately $300 million.

Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Goodness Growth Holdings Launches New Line of Cannabis Edibles

Third quarter 2021 earnings released: US$0.078 loss per share (vs US$0.004 loss in 3Q 2020)

Price target decreased to CA$4.00

Goodness Growth Holdings, Inc. Retail Brand Green Goods® to Offer Medical Cannabis Program Information & Discounts At the Minnesota State Fair

Second quarter 2021 earnings released: US$0.044 loss per share (vs US$0.16 loss in 2Q 2020)

Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Goodness Growth Holdings Subsidiary Resurgent Biosciences Announces Planned Expansion into Psychedelics Research and Ip Development

Vireo Health International, Inc. Provides Revenue Guidance for the Fiscal Year 2022

First quarter 2021 earnings released: US$0.062 loss per share (vs US$0.076 loss in 1Q 2020)

Vireo Health Expands Ground Cannabis Flower in New York, Offers Largest Selection of Ground Flower At Any New York Dispensary

Insider recently sold CA$4.6m worth of stock

Full year 2020 earnings released: US$0.23 loss per share (vs US$0.67 loss in FY 2019)

Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Vireo Health International, Inc. to Report Q4, 2020 Results on Mar 25, 2021

New 90-day high: CA$3.77

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Vireo Health International Inc. Appoints Victor E. Mancebo to its Board of Directors

Price target raised to CA$2.33

New 90-day high: CA$3.09

Vireo Health International, Inc. Launches Amplifi™, the First Terpene-Enhanced Brand of Dry Cannabis Flower

Vireo Health International, Inc. (CNSX:VREO) completed the acquisition of medical and adult-use cannabis cultivation and processing businesses in Nevada.

New 90-day high: CA$1.75

Insider recently sold CA$708k worth of stock